Expert IPO Guidance Grounded in Success
- Sound financial strategy for biotech companies requires long-term planning and execution to position for a successful public listing or acquisition
- The “Dashboard” (pictured) reflects a strategy designed to secure the best “lead left” bank possible and the extensive experience of Collabrity CFOs in managing a biotech company’s public readiness preparations
Collabrity’s Fundraising Solutions for Biotechs
- Our foundational insight is that approximately two-thirds of the work of fundraising is a repetitive, teachable skill-based process.
- While strategic advisory firms churn fees on IR activity with high-priced interim CFOs, we train and deploy Associates cost-effectively, passing savings on to clients.
- As a result, our CFOs are leveraged and free to focus their efforts on the highest, best use of their strategic insights, experience and skills.
Highly-Qualified CFO Support from Collabrity
- Our engagement model is designed to lead to long-term equivalence of the full-time CFO support your company needs – a fully integrated member of your team who has been there for you from the start
- Christopher Lehman’s 30-year career in biotechnology spans business development and financial leadership roles encompassing all aspects of a CFOs responsibilities
- Leadership roles in therapeutics, diagnostics, CRO, and industrial biotech.
- 40 partnering and financing transactions totaling over $1.9 Billion.
- Broad investor network of early and late-stage institutional investors
- Collabrity offers CFOs with comparable skills and experience to lead our expanding number of client engagements
© , all rights reserved
Christopher Lehman, CEO
Mobile (510) 339-3749
Email chris@collabrity.com